Table 2.
Comparison of site distribution of disease in primary and revision cases
| Sites | Primary (n = 129) | Revision (n = 64) | ‘p’ value |
|---|---|---|---|
| Maxilla | 86 (66.7%) | 27 (42.2%) | 0.001 |
| Pre-maxilla | 23 (17.8%) | 11 (17.2%) | Not significant |
| Retro-maxilla | 42 (32.65) | 34 (53.1%) | 0.006 |
| Palate | 38 (29.5%) | 27 (42.4%) | 0.078 |
| Sphenoid sinus | 60 (46.5%) | 47 (73.4%) | < 0.001 |
| Pterygoid wedge | 56 (43.4%) | 48 (75.0%) | < 0.001 |
| GWS | 41 (31.8%) | 44 (68.8%) | Not significant |
| Clivus | 24 (18.6%) | 24 (37.5%) | 0.004 |
| Superior-orbital fissure | 14 (10.9%) | 18 (28.1%) | 0.002 |
| Orbital apex | 11 (8.5%) | 16 (23.4%) | 0.004 |
| Paraclival carotid | 20 (16.5%) | 18 (28.1%) | 0.038 |
| Cavernous sinus | 6 (4.7%) | 3 (4.7%) | Not significant |
| Frontal bone | 3 (2.3%) | 13 (20.3%) | < 0.001 |
| Crista galli | 5 (3.9%) | 7 (10.9%) | Not significant |
| Temporal fossa | 1 (0.8%) | 16 (25.0%) | < 0.001 |
| Zygoma | 2 (1.6%) | 16 (25.0%) | < 0.001 |
| Temporal abscess | 10 (7.8%) | 10 (16.6%) | Not significant |
| Frontal abscess | 6 (4.7%) | 6 (9.4%) | Not significant |